Support:+1 929 202 3014 info@abvigenus.com

Search

Home >>Search
Products(19124) Services(547)
Tetrodotoxin, HRP View>
Cat No£ºABNH9288
Source: Synthetic
Application: ELISA, LF
Bioconjugation
3,3',5-triiodo-L-thyronine-BSA View>
Cat No£ºABSA-0164A
Source: Synthesis
Application: ICA
Bioconjugation
3,3',5-triiodo-L-thyronine-OVA View>
Cat No£ºABSA-0165A
Source: Synthesis
Application: ICA
Bioconjugation
3,3',5-triiodo-L-thyronine-KLH View>
Cat No£ºABSA-0166A
Source: Synthesis
Application: ICA
Bioconjugation
Thyroxine-BSA View>
Cat No£ºABSA-0167A
Source: Synthesis
Application: ICA
Bioconjugation
Thyroxine-KLH View>
Cat No£ºABSA-0168A
Source: Synthesis
Application: ICA
Bioconjugation
Thyroxine-OVA View>
Cat No£ºABSA-0169A
Source: Synthesis
Application: ICA
Bioconjugation
rT3, 3,3',5'-triiodo-L-thyronine-BSA View>
Cat No£ºABSA-0170A
Source: Synthesis
Application: ICA
Bioconjugation
rT3, 3,3',5'-triiodo-L-thyronine-KLH View>
Cat No£ºABSA-0171A
Source: Synthesis
Application: ICA
Bioconjugation
rT3, 3,3',5'-triiodo-L-thyronine-OVA View>
Cat No£ºABSA-0172A
Source: Synthesis
Application: ICA
Bioconjugation
Testosterone-BSA View>
Cat No£ºABSA-0194A
Source: Synthesis
Application: ICA
Bioconjugation
Testosterone-OVA View>
Cat No£ºABSA-0196A
Source: Synthesis
Application: ICA
Bioconjugation
Teicoplanin-BSA View>
Cat No£ºABSA-0230A
Source: Synthesis
Application: ICA
Bioconjugation
Teicoplanin-KLH View>
Cat No£ºABSA-0231A
Source: Synthesis
Application: ICA
Bioconjugation
Teicoplanin-OVA View>
Cat No£ºABSA-0232A
Source: Synthesis
Application: ICA
Bioconjugation
Tacrolimus-BSA View>
Cat No£ºABSA-0251A
Source: Synthesis
Application: ICA
Bioconjugation
Tacrolimus-KLH View>
Cat No£ºABSA-0252A
Source: Synthesis
Application: ICA
Bioconjugation
Tacrolimus-OVA View>
Cat No£ºABSA-0253A
Source: Synthesis
Application: ICA
Bioconjugation
Teicoplanin, BCP View>
Cat No£ºABSPA-B08A
Source: Synthesis
Application: Immunology
Bioconjugation
Tacrolimus, BCP View>
Cat No£ºABSPA-B13A
Source: Synthesis
Application: Immunology
Bioconjugation
Total 6 PagePage: 3/6 PageHome234Last